Free Trial
NASDAQ:PETV

PetVivo (PETV) Stock Price, News & Analysis

PetVivo logo
$0.76 -0.04 (-5.00%)
As of 03:41 PM Eastern

About PetVivo Stock (NASDAQ:PETV)

Key Stats

Today's Range
$0.76
$0.80
50-Day Range
$0.40
$0.95
52-Week Range
$0.29
$1.34
Volume
18,537 shs
Average Volume
33,424 shs
Market Capitalization
$16.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Receive PETV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetVivo and its competitors with MarketBeat's FREE daily newsletter.

PETV Stock News Headlines

PetVivo appoints Mike Eldred as commercialization, operations advisor
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?
See More Headlines

PETV Stock Analysis - Frequently Asked Questions

PetVivo's stock was trading at $0.62 at the beginning of 2025. Since then, PETV shares have increased by 22.6% and is now trading at $0.76.
View the best growth stocks for 2025 here
.

PetVivo Holdings, Inc. (NASDAQ:PETV) released its earnings results on Thursday, June, 29th. The company reported ($0.21) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.21). The firm had revenue of $0.13 million for the quarter. PetVivo had a negative trailing twelve-month return on equity of 1,213.96% and a negative net margin of 889.99%.

Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PetVivo investors own include HubSpot (HUBS), ForgeRock (FORG), Netflix (NFLX), Sportradar Group (SRAD), Dutch Bros (BROS) and ConocoPhillips (COP).

Company Calendar

Last Earnings
6/29/2023
Today
2/04/2025
Next Earnings (Estimated)
2/10/2025
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PETV
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Net Income
$-10,950,000.00
Net Margins
-889.99%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$970,000.00
Book Value
$0.07 per share

Miscellaneous

Free Float
19,012,000
Market Cap
$16.20 million
Optionable
Not Optionable
Beta
2.36
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:PETV) was last updated on 2/4/2025 by MarketBeat.com Staff
From Our Partners